Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

Virtual Care Provider Zipnosis Secures Capital Investment from Arthur Ventures

Partnership will Help Accelerate New Market Growth for SaaS Company

Minneapolis, MN (Nov. 18, 2014) – Arthur Ventures, a venture capital firm focused on software companies in the healthcare market, has invested in the seed round for SaaS start-up, Zipnosis, a simple-to-use online diagnosis and treatment option for minor health conditions (www.zipnosis.com).

Minneapolis-based Zipnosis partners with health systems across the country to power virtual care services that are white labeled. By connecting patients and local clinicians online, Zipnosis makes mainstream medicine not only affordable, but easily accessible to anyone with a web-enabled device.

According to new research by Deloitte, 75 million “virtual” doctor visits, or 1 in 6 will occur this year alone. Revenue in the telehealth services industry is expected to increase by an annualized 30.7 percent to $320.2 million in the next five years, including revenue growth of 23.1 percent in 2014, according to a new report from market researcher IBISWorld.

“We recognize the increasing role telehealth will play in improving the country’s existing healthcare landscape,” said James Burgum, managing partner of Arthur Ventures. “Arthur Ventures invests in businesses that help solve clearly defined problems by leveraging the power of technology as a business amplifier and accelerator. We believe Zipnosis is making it easier and faster to connect for care—impacting healthcare delivery in our country by improving access and increasing clinical capacity.”

“Arthur Ventures’ investment will help accelerate our exponential, organic growth over the next two years,” said Zipnosis Co-Founder and CEO Jonathan Pearce.  “Their experience growing massively successful software companies provides Zipnosis with key strategic guidance through this exciting phase of our company.”

Through the Zipnosis platform, patients can receive prompt, high-quality care for common medical conditions such as sinus infections, female bladder infections, pink eye, or cold, cough and flu through via mobile phone, computer and tablet—all for a flat-rate $25-$35 service fee payable by a credit card or health savings card.

The company’s asynchronous model ensures adherence to evidence-based medicine, while guiding connections between clinicians and patients. The platform is incredibly efficient, leading clinicians to provide diagnosis and treatment for common ailments in less than two minutes a visit.  Additionally, the platform attracts new patients to a health system, building an incremental revenue stream for hospitals without adding additional clinical headcount.

About Zipnosis:

As one of the nation’s leading virtual care providers, Minneapolis-based Zipnosis is defining digital medicine, providing virtual care for common medical conditions from the convenience of a web-enabled device. Founded in 2008, the company is continuing to improve patient care one click at a time by making it easy for patients and providers to connect online. Whether through Zipnosis.com or its white label product offered by hospital and clinic partners around the country, users can be diagnosed, treated and triaged if necessary, to the appropriate level of care—receiving infallible care in a manner that is most convenient to them. Zipnosis’ asynchronous model ensures compliance to the evidence-based clinical guidelines by more than 70 percent for many of the conditions it treats. Find out more about Zipnosis, at www.zipnosis.com, Facebook.com/Zipnosis, and Twitter.com/Zipnosis.

About Arthur Ventures:

Founded in 2008, Arthur Ventures is a venture capital firm focused on early-stage software companies. The firm has offices in Fargo, North Dakota and Minneapolis, Minnesota.  Additional information on Arthur Ventures can be found at www.arthurventures.com.

November 18, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Xerox and HealthSpot to Expand Telehealth Access in the US

Norwalk, Conn. — November 12, 2014 In a move that expands patient access to care,Xerox (NYSE: XRX) is investing in HealthSpot Inc., a pioneer in patient- and provider-driven healthcare technology. The investment enables groundbreaking telehealth to be delivered to patients in convenient locations nationwide.

Through proprietary cloud-based telemedicine software the HealthSpot® platform allows patients to interact with nationally recognized doctors. The average visit to one of HealthSpot’s fully enclosed, 40-square foot kiosks takes 15 minutes, offering patients convenient, timely access to doctors, specialists and prescriptions.

The investment from Xerox means HealthSpot can rapidly scale deployment of its kiosks and access Xerox’s relationships across the healthcare industry. Over the next five years, HealthSpot plans to deploy kiosks to retail pharmacies, large employers, long-term care centers and emergency departments throughout the nation.

“HealthSpot is at the center of healthcare’s shift to a patient-centered model of care, and our investment in the company demonstrates Xerox’s commitment to transforming traditional healthcare into a high-value delivery system for patients, providers and payers,” said Connie Harvey, chief operating officer of Commercial Healthcare for Xerox. “By combining the HealthSpot platform with our powerful brand and more than 40 years of healthcare experience, we’re helping patients unlock affordable access to care while positioning Xerox to play a significant role in the future of healthcare.”

Xerox is also partnering with HealthSpot to combine its software platform with Xerox’sbusiness process services expertise. As the exclusive BPO provider, Xerox will deliver cloud hosting, system integration, claims eligibility and claims submissions solutions. The kiosk will use Xerox’s IT infrastructure for appointment booking, as an interface to electronic health records and for insurance coordination.

“Telehealth is recognized as a solution for access, but to become a true extension of traditional healthcare requires more than just a mobile app and a videoconference with patients. We need an integrated and secure IT offering that is scalable, and our Xerox partnership will do just that,” said Steve Cashman, HealthSpot CEO. “Xerox is a dominant leader in healthcare services today, reaching two out of every three U.S.-insured patients and working with most U.S. states. Together with providers, payers and a powerful IT foundation, we will bring patients the evolution in care that they’ve long been waiting for.”
The terms of the investment were not disclosed.

# # #

About Xerox

Xerox is a global business services, technology and document management company helping organizations transform the way they manage their business processes and information. Headquartered in Norwalk, Conn., we have more than 140,000 Xerox employees and do business in more than 180 countries. Together, we provide business process servicesprinting equipment, hardware and software technology for managing information — from data to documents. Learn more atwww.xerox.com.

Xerox® Xerox and Design® are trademarks of Xerox in the United States and/or other countries.

About HealthSpot®HealthSpot® is healthcare, reimagined. A pioneer in connected care, HealthSpot has built a comprehensive healthcare delivery platform that combines cloud-based software with the award-winning HealthSpot station, digital medical devices and mobile applications. HealthSpot’s platform radically transforms today’s healthcare system by enabling the delivery of quality, affordable medical care through a diverse professional care network for patients in efficient, convenient locations like pharmacies, hospitals, clinics, employer and community sites, universities and the home. For more information on HealthSpot, go to www.healthspot.net.

The HealthSpot name and logo are registered marks of HealthSpot Inc. 

November 12, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Modernizing Medicine Closes First $15M Tranche of Expected $20M Round of Funding

New round of funding led by Summit Partners and Pentland Group is expected to support product development, market expansion and company growth

Boca Raton, Florida – November 11, 2014 – Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, specialty-specific electronic medical record (EMR) system, announced that it has closed on approximately $15M of an expected $20M funding round. The latest funding comes from existing investors, led by Summit Partners and Pentland Group, many of whom are medical specialists who use EMA.

“At Modernizing Medicine we believe that properly captured and leveraged health data has the power to increase efficiency, improve patient outcomes and transform healthcare,” said Daniel Cane, CEO and co-founder of Modernizing Medicine. “This latest round of funding reinforces that belief and the strength of our market-differentiating products and services. With the investment we intend to continue focused development in the surgical-specialties, while also committing resources for development in telemedicine, IBM Watson and mobile applications.”

Developed by surgical physicians, EMA contains built-in specialty-specific medical knowledge and workflows. It can be accessed via the Internet virtually anywhere and at any time. This flexible format, combined with EMA’s touch-screen interface and advanced ICD-10 capabilities, gives providers the freedom they need to focus on their patients with the reassurance that charting plus coding for billing can be completed at the point of care.

Currently serving eight different medical specialties, more than 4,000 providers have adopted Modernizing Medicine’s EMA in their practices.

“Healthcare professionals need tailored technologies that make it easy not only to manage but also benefit from the exploding amounts of patient data,” said Michael Sherling, MD, Modernizing Medicine’s co-founder and chief medical officer. “In a relatively short time, we have developed a solution that does just that, enabling us to capture substantial market share and emerge as a physician-favorite EMR system. In the dermatology specialty alone, more than 26 percent of U.S. dermatologists now use EMA.”

Modernizing Medicine continues to be recognized for its exceptional culture, leadership and growth. The company expects its employee base to continue to grow with approximately 100 new positions being created in the next 12-18 months. Co-founders Cane and Sherling were recently honored with the Leadership in Health Care Award by the U.S. Chamber of Commerce. The company was also named in Red Herring’s Top 100 North America list, which recognizes the top private companies across the continent that are expected to achieve significant growth in the near future.

About Modernizing Medicine

Modernizing Medicine® is transforming how healthcare information is created, consumed and utilized in order to increase efficiency and improve outcomes. Our product, Electronic Medical Assistant® (EMA™), is a cloud-based, specialty-specific electronic medical record (EMR) system with a massive library of built-in medical content. Available as a native iPad application or from almost any web-enabled Mac or PC, EMA adapts to each provider’s unique style of practice and is designed to interface with hundreds of different practice management systems. Today, Modernizing Medicine provides specialty-specific offerings for the dermatology, ophthalmology, orthopedics, otolaryngology, gastroenterology, rheumatology, urology and plastic and cosmetic surgery markets and to more than 1,400 physician practices across the country.

November 11, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Qualcomm and The George Institute for Global Health Establish the China Center for mHealth Innovation

New Initiative Designed to Support the Development of Community Healthcare and Contribute to Mobile Health Innovation in China

Qualcomm Incorporated, through its Qualcomm® Wireless Reach™ initiative, and The George Institute for Global Health, a not-for-profit medical and healthcare research organization dedicated to improving global health, today announced that they are collaborating on the creation of the China Center for mHealth Innovation (CCmHI) to support the Chinese central government’s goal, as stated in the Twelfth Five Year Plan (2011-2015), of improving community healthcare in China.

Hosted by The George Institute for Global Health at Peking University Health Science Center and funded by Qualcomm Wireless Reach, CCmHI is positioned to become a world-class center for mobile health (mHealth) innovation. Working with central and provincial governments, CCmHI will help improve community healthcare in China by developing mHealth solutions, implementing clinical evaluations and contributing to strategies for the implementation and scale-up of effective and affordable mHealth tools.

CCmHI’s main priorities are to:

  • Build Chinese capacity in digital healthcare development and evaluation, including providing opportunities for student internships and fellowships.
  • Develop and evaluate mHealth platforms designed to provide community healthcare workers with evidence-based, personalized guidance about the care of individual patients.
  • Target the 10 leading causes of premature death and disability in China.
  • Provide solutions that are effective in both urban and rural settings.
  • Assist with the integration of mHealth strategies into national and provincial policies and guidelines.
  • Support the development and expanded use of mHealth technologies globally.

Initially, CCmHI will conduct a landscape analysis of digital health policies, laws, standards, programs and research activities in China, all of which will inform CCmHI’s pilot and flagship research efforts. CCmHI aims to develop and field test at least one mHealth program for chronic disease management in its first year, which will lead to larger scale mHealth programs in future years.

China’s Twelfth Five Year Plan (2011-2015) prioritizes the development of affordable, quality, and accessible healthcare for the entire population. CCmHI will contribute to this goal through the development of innovative mobile technology solutions designed to improve community healthcare services. CCmHI aims to support the central government’s deepened commitment to healthcare reform in the Third Plenum late last year, which includes improving technological advancement and development of the healthcare field and strengthening healthcare professionals’ capacity.

With the rapid expansion of mobile internet connectivity across China, the potential exists to affordably create and link sophisticated digital health systems for healthcare workers, electronic health records, point-of-care diagnostics and systems that will enable regional health authorities to monitor and manage the quality and outcomes of community healthcare. Combined with consumer applications that provide tools for self-care using secure data transfer to a cloud-based server, these new digital health systems can enable solutions to healthcare delivery obstacles.

“The George Institute is proud to collaborate with Qualcomm in the establishment of CCmHI as a world-class center for mHealth innovation,” said Stephen MacMahon, Principal Director of The George Institute for Global Health and Honorary Professor of Public Health at the Peking University Health Science Center. “There is a pressing need for fresh approaches to community healthcare in China and globally, particularly in resource-poor areas. CCmHI will address this need by developing new mHealth strategies designed to improve care for individuals at high risk of stroke and other prevalent causes of premature death and disability.”

“Qualcomm appreciates the opportunity to work with The George Institute to help advance community healthcare in China,” said Steve Mollenkopf, chief executive officer, Qualcomm Incorporated. “Since 2006, Wireless Reach has led programs that leverage advanced wireless technologies to achieve economic and social impact in underserved areas throughout China. To date, these programs have directly or indirectly benefitted nearly 850,000 people. Our investment in CCmHI is part of our continuing commitment to improve the lives of Chinese citizens and contribute to the creation of an innovation-based economy in China.”

About The George Institute for Global Health and George Institute China

The George Institute for Global Health is a non-profit medical and healthcare research organization with a mission to improve the health of millions of people worldwide by providing the best evidence to guide critical health decisions, engaging with decision-makers to enact real change, targeting global epidemics – particularly of chronic diseases and injury – and focusing on vulnerable populations in both rich and poor countries. Established in 1999 in Australia and affiliated with The University of Sydney, the Institute today has 4 centres in Australia, China, India and the United Kingdom. It is affiliated with Peking University Health Science Center in China, the University of Hyderabad in India and the University of Oxford in the United Kingdom.

The establishment of the China-Australia Partnership for Health in 2004 marked the beginning of the Institute’s development in China. The George Institute for Global Health China was officially launched in 2007, and in 2012 it was designated an official affiliate of PUHSC.  Today the Institute is one of China’s leading independent health research organizations working in partnership with governments, universities, hospitals and healthcare centres across China.

Globally, The George Institute has projects in more than 50 countries, has raised more than $500 million for global health research, and has been ranked among the top 10 research institutions in the world for scientific impact by the SCImago Institution Rankings World Report in 2011-2013.

About the Qualcomm® Wireless Reach™ Initiative

Qualcomm® Wireless Reach™ is a strategic initiative that brings wireless technology to underserved communities globally. Wireless Reach invests in projects that foster entrepreneurship, aid in public safety, enhance the delivery of health care, enrich teaching and learning and improve environmental sustainability. Formalized in 2006, Wireless Reach has grown to include 105 projects in 40 countries that use advanced wireless technologies to advance social and economic development. To learn more about the Wireless Reach initiative, please visit our website

November 10, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Kareo Secures $15 Million in Mezzanine Debt from Escalate Capital Partners

Latest investment brings total capital raised in 2014 to $47MM, new capital will be used to further expand Kareo’s cloud-based solutions for independent physicians

Irvine, CAOctober 24, 2014 Kareo, the leading provider of cloud-based medical office software for small medical practices, today announced that it has received $15 million in mezzanine debt from Escalate Capital Partners, an institutionally backed mezzanine fund that invests in high growth companies in the technology, healthcare and Software-as-a-Service (SaaS) industries. In 2014, Kareo has secured a total of $47 million in funding, reinforcing the company’s unprecedented growth and further enhancing Kareo’s role as the independent physician’s trusted partner.

Kareo enables independent physicians and their staff to streamline patient engagement, clinical documentation, billing, and other critical administrative processes in order to focus on what matters most—providing quality patient care. The $15 million in new growth capital will be used to further expand Kareo’s reach and deepen its solution set to meet inevitable demand due to patient-driven shifts in the industry, while accelerating the development and innovation of the company’s cloud-based technology.

“The shift toward consumer-driven care is continuing to gain momentum,” says Dan Rodrigues, founder and CEO of Kareo, “and we believe that independent practices are uniquely positioned to benefit from this trend and provide the most appropriate and highest quality care to patients. We are delighted to have the backing and confidence of Escalate as we further enhance our products to better support small practices.”

Kareo’s mission has been affirmed by its significant growth. The company has been consistently recognized as one of the fastest growing private companies in the U.S., realizing a 552 percent increase in revenue over the past three years. The company now serves more than 25,000 healthcare providers with its award-winning EHR, practice management and billing services platform, and is adding more than 500 provider customers per month.

“Kareo’s unique business model and market-leading solutions are changing the game in healthcare IT,” says Ross Cockrell, managing director at Escalate Capital Partners. “There is considerable market opportunity for Kareo as independent physicians provide the majority of patient care in the United States. And with increasing focus on fee-for-quality reimbursement models, this trend will likely continue. Kareo is well poised to sustain its growth record and we are excited to be a part of its continued success.”

The latest financing brings Kareo’s total capital raised to $90 million. New investor Escalate Capital Partners joins Kareo’s group of top-tier institutional investors which also include OpenView Venture Partners, Greenspring Associates, Stripes Group, Silicon Valley Bank and Western Technology Investments.

About Kareo

Kareo is the only cloud-based medical office software and services platform purpose-built for small practices. At Kareo, we believe that, with the right tools and support, small practices can do big things. We offer an integrated solution of products and services designed to help physicians get paid faster, run their business smarter, and provide better care. Our practice management softwarebilling services, and free, award-winning fully certified EHR help more than 25,000 medical providers more efficiently manage the business and clinical sides of their practice. Kareo has received extensive industry recognition, including the Deloitte Technology Fast 500, Inc. 500/5000, Forbes Top 100 Most Promising Companies, and Black Book #1 Integrated EHR, Practice Management and Billing Vendor. Headquartered in Irvine, California, the Kareo mission is to help providers spend their time focused on patients, not paperwork. For more information, visit www.kareo.com.

About Escalate Capital Partners

Escalate Capital Partners is an institutionally backed mezzanine fund that invests in high growth companies and is an ideal partner at the critical growth phase in a company’s lifecycle, offering patient capital tailored to each company’s unique needs. Escalate Capital has built a track record as a valued and committed partner through periods of robust growth and economic uncertainty. The Escalate Capital investment team has a combined 75+ years of experience and has invested more than $2 billion in over 500 companies.

October 24, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Exostar Obtains $5 Million Investment for their Growing Healthcare Business

HERNDON, VA, October 7, 2014Exostar, an innovative information technology company offering cloud-based solutions that enable secure, cost-effective business-to-business collaboration, today announced a $5.0 million investment to enable them to accelerate the growth and expansion of their healthcare and life science business.

Exostar’s cloud-based authentication identity hub for the healthcare industry, Secure Access Manager (SAM), connects customers with other organizations securely across large communities of users. The investment, made by the Merck Global Health Innovation Fund, will help Exostar maintain its rapid growth in these markets and expand into related verticals.

The healthcare industry continues to become more reliant on secure connections, not only to ensure organizations meet all compliance issues, but to support critical digital health applications such as ePrescribing, Health Information Exchange (HIE), and clinical collaboration.  Exostar leverages over a decade of experience helping companies access, utilize and share business-critical information and applications through an easy-to-use, secure Software as a Service (SaaS) model.

“Exostar has successfully expanded from its Aerospace & Defense heritage into other vertical markets that have similar requirements for secure collaboration, complex supply chain needs or identity management to support their core business processes,” said Richard Addi, Exostar’s CEO.  “Our solution is an ideal fit for the healthcare and life science community that needs to set up connections with partners and their applications quickly and securely.  Exostar helps its customers connect with thousands of partners in their ecosystem without compromising network security or intellectual property.”

Originally established by some of the largest companies in the pharmaceutical and life sciences industry, the Exostar life sciences identity hub today includes more than 600 life science focused companies, government agencies and universities supporting the collaboration initiatives of thousands of individuals.

“Exostar’s secure cloud-based access and existing user base delivers a strong complement to the current and future needs of the data-driven healthcare industry,” said Joe Volpe of Merck’s Global Health Innovation Fund.

About Exostar

Exostar powers secure business-to-business information sharing, collaboration and business process integration throughout the value chain.  Exostar supports the complex trading needs of many of the world’s largest companies in aerospace and defense, life sciences, and other industries.  Exostar’s cloud-based identity assurance products and business applications reduce risk, improve agility and strengthen trading partner relationships and profitability for over 100,000 companies in 150 countries worldwide.  The Exostar community includes market leaders such as AstraZeneca, BAE Systems, Bell Helicopter, The Boeing Company, Computer Sciences Corporation, Lockheed Martin Corp., Merck, Newport News Shipbuilding, Northrop Grumman, Raytheon Co. and Rolls-Royce.  For more information, please visit www.exostar.com.

About Merck Global Health Innovation Fund, LLC

Merck Global Health Innovation Fund, LLC (GHIF) invests in emerging companies that deliver breakthrough health care solutions, which advance Merck’s mission to discover, develop and provide innovative products and services that save and improve lives. For more information, visit http://www.merck.com/ghi.

October 7, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Nextech to Acquire MDIntelleSys, the Leading Cloud-Based EHR for Eye Care

Tampa, Florida – October 2, 2014 – Nextech Systems, a leading provider of specialty-focused healthcare technology solutions for physician practices, and MDIntelleSys (MDI), a leading cloud-based electronic health record (EHR) for ophthalmologists, today announced that they have entered a strategic agreement in which Nextech will acquire MDI. The acquisition of MDI effectively doubles Nextech’s ophthalmology market share while adding clinical depth and ophthalmic expertise to Nextech’s suite of solutions. It will also allow Nextech to immediately provide its cloud-based practice management solutions to MDI customers.

“This strategic acquisition strengthens Nextech’s position as the industry leader in specialty-specific healthcare IT solutions, and by combining our product portfolio with MDI, we will be able to offer a collective SaaS presence in our markets,” says David Henriksen, CEO of Nextech. “Together, MDI and Nextech will drive product innovation and deeper engagement with our customers and partners to support the unique needs of specialty physicians.”

Nextech is the largest specialty-specific EHR provider and is the only specialty EHR to be ranked in Medscape’s “Top Favorite EHR List.” Nextech’s industry leading position is supported by the strategic experience and financial strength of healthcare technology focused private equity firm Francisco Partners. In October of last year, Francisco Partners made a strategic investment in Nextech due to its strength and stability as the largest all-in-one specialty specific solution. Through this acquisition, MDI clients are now able to take advantage of Nextech’s full product suite of integrated solutions, including practice management, marketing, inventory and optical shop management modules. These customers will also gain access to Nextech’s consultative services with regard to meeting requirements for meaningful use and ICD-10.

“It is the goal of both Nextech and MDI to capitalize on our joint success in the ophthalmology market to further advance our solution offerings,” says Dan Montzka, MD, founder, chairman and CEO of MDIntelleSys. “This transaction will enhance both companies’ offerings immensely, better serving the needs of more than 25,000 ophthalmologists in the United States alone.”

By joining forces with MDI, which ranked number one in nine categories on the American Society of Ophthalmic Administrators (ASOA) 2013 EHR Customer Satisfaction Survey, Nextech is able to further extend its position as the premier specialty-specific solution for ophthalmology practices. Nextech will leverage MDI’s Software as a Service (SaaS) capabilities to expand the company’s cloud offering, extending the usability and reach of Nextech’s integrated solution. Nextech will now offer both a client-server model and cloud-based solution to meet each practice’s unique needs.

“Over the years, I have admired MDI’s excellence in customer service, clinical product focus and its unique SaaS offering.   A testament to the leadership and passion of Dr. Montzka and his team,” says Dr. Kamal Majeed, Founder and Board Member of Nextech. “Combined with Nextech’s all-encompassing products and mobile platforms, this partnership creates a powerful and most unique offering in the market.”

Dr. Dan Montzka will assume the role of Chief Medical Officer at Nextech. While still subject to customary closing conditions, MDIntelleSys, LLC will now be known as MDIntelleSys, a Nextech company. The product portfolios from both companies will continue to move forward as Nextech and MDI work to advance and combine their respective solution offerings.

About Nextech

Nextech deploys specialty-focused healthcare technology for physician practices. As a trusted advisor to thousands of specialty providers since 1997, Nextech delivers consultative guidance, professional services and innovative tools that enable clients to increase efficiencies while meeting their long-term business goals. The company’s robust solutions integrate seamlessly with value-added modules to create a single, intuitive platform that streamlines clinical, administrative, financial and marketing workflows. To learn how Nextech’s advanced offerings help specialty providers succeed in a fast-changing healthcare environment, visitwww.nextech.com.

About MDIntelleSys

MDIntelleSys, A Nextech Company, located in Clearwater, Florida designs, develops and markets intelligent healthcare solutions for ophthalmologists. MDI’s electronic health records (“EHR”) software, called IntelleChart, is the leading cloud based EHR specifically designed for eye care specialists. For additional information visit: www.mdiehr.com.

About Francisco Partners 

Francisco Partners is a global private equity firm that specializes in investments in technology companies. Since its launch over a decade ago, FP has raised approximately $7 billion and invested in more than 100 technology companies, making it one of the most active investors in the industry.  The firm invests in transaction values ranging from $50 million to over $2 billion, where the firm’s deep sub-sector knowledge and operational expertise can help a company realize its full potential. For further information, please visit: www.franciscopartners.com.

October 6, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Pristine Raises $5.4 Million in Series A Funding

Led by S3 Ventures, funding will fuel growth of HIPAA-Compliant enterprise communication solutions for Google Glass

AUSTIN, TX

Pristine, developers of the only HIPAA-compliant video streaming and checklist solutions for Google Glass, announced today that it has raised $5.4 million in Series A financing. Austin-based S3 Ventures led the oversubscribed round, which also included Capital Factory, HealthFundr, and a syndicate of strategic clients. This new financing enables the company to expand its R&D, sales, marketing, and operations teams, supporting the company’s rapid growth.

“The team at S3 has pioneered cutting-edge developments in medical devices, enterprise health IT solutions, and more,” said Kyle Samani, cofounder and CEO of Pristine. “With our rapid growth, we are thrilled to have partners with a strong track record of guiding early stage companies to success.

Pristine was born from a common refrain in healthcare: “Hey, can you come over here and look at this?” In response, the company developed EyeSight, the first commercially available, HIPAA-compliant telepresence platform for Google Glass. EyeSight is also finding success outside of healthcare, working with pharmaceutical, medical device, and manufacturing companies on remote support and training applications.

“Wearable technologies like Google Glass are revolutionizing how healthcare is delivered, and the Pristine platform is the market leader,” said Brian R. Smith, Managing Director at S3 Ventures. “Current customers are raving about the product, and we are excited to partner with Pristine to continue innovating in healthcare, as well as remote support applications in other industries.”

“We have deployed EyeSight in ERs, ORs, ICUs, ambulances, and even patients’ homes,” added Samani. “We understand that security is paramount. There is a lot of misinformation about Glass and privacy out in the wild; we have gone the extra mile to guarantee security and control for our clients. Our utmost focus on security will fuel our growth as we scale our wearable communication technology throughout healthcare and across other industries.”

About Pristine

Pristine is pioneering the next generation of telepresence in healthcare and other industries. EyeSight, Pristine’s flagship app, enables HIPAA-compliant audio/video streaming across every platform–Mac, PC, iPhone, iPad, Android, Google Glass, and other smart glass devices. EyeSight is currently in use for patient care across ERs, ORs, ICUs, ambulances, as well as in

medical education and medical device service. More information can be found at www.pristine.io, pristine.io/blog, and by following @PristineIO on Twitter

About S3 Ventures

S3 Ventures is an earlier stage venture firm with $185 million under management. The firm is focused on information technology solutions that solve large business problems and in medical devices that improve the human condition. S3 invests primarily in the formative stages of a company and partners with the team to help focus methodically on what it takes to build a successful company. For more information about S3, visit http://www.s3vc.com.

September 29, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Healthsense Closes $10 Million Financing with Boston-Based Mansa Capital

Boston, Mass. & Minneapolis, Minn. – Aug. 19, 2014 – Healthsense,® Inc., the fastest growing provider of technology-enabled care solutions for the senior care continuum, announced today that it has closed on $10 million in financing led by Mansa Capital, a Boston-based  private equity firm focused on the $2.8 trillion U.S. healthcare market. Previous investors Merck Global Health Innovation Fund and Radius Ventures LLC also participated in the round.
 
“Mansa Capital possesses exceptionally strong relationships that Healthsense can leverage to expand our reach into the managed care and home health markets, where we see major growth opportunities. This is an ideal complement to our thriving senior living business,” said Healthsense President and CEO A.R. Weiler“Mansa Capital’s involvement will extend the exceptional benefits we have realized from previous investments with Merck GHI, Radius and B.C. Ziegler and Company, influential investors whose market knowledge and resources have helped us achieve our continued growth and success.”
 
With Healthsense’s growing focus on helping managed care organizations optimize care, the firm has deployed several pilot programs within the last year including partnerships with Humana Cares/Senior Bridge, Fallon Health, and various others. Early program results suggest a positive impact of the Healthsense eNeighbor® remote monitoring platform on improving care outcomes for those with chronic health conditions by providing earlier interventions and readmission rate reductions in various care environments.  

“We seek to engage with companies that demonstrate both strong growth potential and the ability to advance the healthcare industry’s Triple Aim of improving care, reducing costs and enhancing the patient experience,” said Mansa Capital Managing Partner and Chief Investment Officer Ruben King-Shaw Jr., who will join the Healthsense Board of Directors. “Healthsense embodies all that we look for when considering an addition to our healthcare portfolio, particularly given the ever-increasing industry focus on managed care.”

Headquartered in Boston, Mansa Capital invests primarily in high-growth healthcare services and technology companies with experienced management teams, sound business franchises and substantial potential. The healthcare private equity investment firm seeks to develop companies that deliver advances in cost-effective care, demonstrate potential for strong organic revenue growth, and exhibit attractive margins as well as high returns on capital.
 



About Healthsense, Inc.
Healthsense is the fastest growing provider of technology-enabled care solutions for the senior care continuum. With a full range of remote monitoring, emergency response and wellness management solutions, Healthsense helps senior care providers and managed care organizations significantly reduce costs, increase independence and enhance caregiver and senior experiences. Built on a wireless platform, Healthsense products are scalable and enable flexible technology-enabled care designs that help in the delivery of the highest quality care across the entire care continuum. Visit www.healthsense.com for more information.

About Mansa Capital
Headquartered in Boston, Mass., with offices in New York City, Miami and Dallas, Mansa Capital is a private equity firm focused on the $2.5 trillion healthcare sector in the U.S. including Puerto Rico and the U.S. Virgin Islands. The firm uses its expertise in healthcare policy and economics to help management teams grow top line revenues and develop new products that build exceptional value. Mansa Capital’s principals bring to the firm extensive expertise in healthcare operations, marketing and finance including senior-level experience in healthcare compliance, regulation and reimbursement. The team has distinctive knowledge in the early identification of innovative business models that enable patients and providers to thrive in the post-healthcare reform environment. The firm also has special insights in the largely untapped Hispanic healthcare market. Visit www.mansancapital.com for more information. 

August 19, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.

Epion Health Receives $4.5M Series A Funding from Deerfield Management

ROSELAND, N.J.July 18, 2014 /PRNewswire/ — Epion Health announced the closing of a $4.5M Series A financing round with Deerfield Management Company, a New York City based investment firm. The funding will be used to scale Epion’s rapidly growing, iPad based, digital check-in and patient engagement platform used in healthcare facilities around the country.

This news comes on the heels of Epion’s recent announcement of a partnership and successful integration with athenahealth. Epion’s solution is now live and available to Athena’s network of 52,000 plus providers.

At the announcement, Epion’s CEO, Joe Blewitt said, “This additional capital comes into the company at an exciting time. We now have the necessary resources for the foreseeable future to capitalize on a very large market opportunity. In addition to growing our sales and operations teams, a portion of the funding will be used to continue to enhance our product for our rapidly growing network of providers. Our focus is on helping our providers increase revenues, decrease costs and improve patient satisfaction and patient outcomes. We’re excited to be partnering with Deerfield Management. In addition to deep pockets, Deerfield brings strong healthcare industry expertise and an extremely robust research arm to the table.”

Deerfield is committed to supporting innovative healthcare technology solutions and is excited about Epion’s ability to both improve practice level economics as well as enhance clinical care and patient experience,” remarked Leslie Henshaw, a Partner at Deerfield Management.

About Epion Health

Epion Health is a Healthbox Accelerator alumni company and offers a software as a service, patient engagement platform at the point of care, beginning with the patient check-in process. By replacing clipboards and paper forms with iPads, Epion improves efficiencies and engages patients to improve outcomes. The service fully integrates with Electronic Health Record and Practice Management systems.

About Deerfield Management Company 

Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information about Deerfield, please visit www.deerfield.com

July 22, 2014 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 15 blogs containing almost 6000 articles with John having written over 3000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 13 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit.